NCT03892967View on ClinicalTrials.gov

Enhanced, EHR-facilitated Cancer Symptom Control Pragmatic Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

50,207

Participants

Timeline

Start Date

March 28, 2019

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Interventions
OTHER

Interview

Participate in interview

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER